ETANERCEPT
etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes],
1 pack
ETANERCEPT (3448L)
3448L
Manner of administration:Injection
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: First continuing treatment
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment - balance of supply
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Subsequent continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $846.44 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Enbrel | |||||